Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178588
Status:
RECRUITING
Last Update Posted:
2024-02-22
First Post:
2023-12-09
Brief Title:
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced Recurrent or Metastatic Cholangiocarcinoma
Sponsor:
University of Kansas Medical Center
Organization:
University of Kansas Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Locally Advanced Cholangiocarcinoma |
| Metastatic Cholangiocarcinoma |
| Recurrent Cholangiocarcinoma |
| Stage III Hilar Cholangiocarcinoma AJCC v8 |
| Stage III Intrahepatic Cholangiocarcinoma AJCC v8 |
| Stage IV Hilar Cholangiocarcinoma AJCC v8 |
| Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 |
Keywords: